A rating of 85 puts TRACON Pharmaceuticals Inc (TCON) near the top of the Biotechnology industry according to InvestorsObserver. TRACON Pharmaceuticals Inc's score of 85 means it scores higher than 85% of stocks in the industry. TRACON Pharmaceuticals Inc also received an overall rating of 66, putting it above 66% of all stocks. Biotechnology is ranked 32 out of the 148 industries.

Finding the best stocks can be tricky. It isnt easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObservers tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObservers overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. Theres no need to try to remember what is good for a bunch of complicated ratios, just pay attention to which numbers are the highest.

TRACON Pharmaceuticals Inc (TCON) stock is up 7.42% while the S&P 500 is flat 0% as of 9:44 AM on Friday, Sep 25. TCON is higher by $0.36 from the previous closing price of $4.86 on volume of 4,725 shares. Over the past year the S&P 500 has gained 9.03% while TCON is higher by 11.30%. TCON lost -$4.46 per share the over the last 12 months.

Click Here to get the full Stock Score Report on TRACON Pharmaceuticals Inc (TCON) Stock.

Read more here:
Where Does TRACON Pharmaceuticals Inc (TCON) Stock Fall in the Biotechnology Field? - InvestorsObserver